Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.
about
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infectionsAntimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance MechanismsCarbapenemase-producing Klebsiella pneumoniae.A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii.Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistanceIn Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic TreatmentThe role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care UnitNorharmane Matrix Enhances Detection of Endotoxin by MALDI-MS for Simultaneous Profiling of Pathogen, Host, and Vector Systems.Putting on the brakes: Bacterial impediment of wound healing.Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteriaIn Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.Clinical Efficacy of Polymyxin Monotherapy versus Nonvalidated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacillus Infections.In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.Recipient-born bloodstream infection due to extensively drug-resistant Acinetobacter baumannii after emergency heart transplant: report of a case and review of the literature.Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic ManagementIn vivo activity of vancomycin combined with colistin against multidrug-resistant strains of Acinetobacter baumannii in a Galleria mellonella model.Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms.In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains.
P2860
Q26991886-4AE5C365-26CE-4508-A9A5-E132E9B70614Q28550908-D4AC6D71-3151-4958-AF82-1F712514566AQ34201937-476DBF68-F2F9-436F-B1CD-64B5F00C5F03Q34726120-1C3806D5-2A09-4F0E-8987-7EADF9C9DE2DQ35105947-2789F09C-91F4-44A7-B184-9BD7BB64AC2BQ35551122-B48D1320-0EF1-4DF7-B88E-5A70B378C973Q35662086-DC731D2E-8141-4ADA-9D65-9BC2BC85D4DBQ35794409-90BBB7A2-A423-471B-A4B7-C99E2E688C34Q36138907-50A47E7B-3CAA-4A1F-8DD4-79F468D1343DQ36293244-296DFA38-4FDF-4CE8-B63F-BF52B7910F45Q36299428-7EF4B67B-7840-4270-9B92-FEAB62064C0AQ36465442-5FA67C60-F2E4-4E3B-8FF9-D3C00185540CQ37023227-4A1FCBCE-E7F2-4D89-98D1-8ABC6763E2E9Q37358693-D4F8A58C-4B7E-405E-B315-F06E675F5A85Q37544860-6998587F-8622-432E-902D-1C2120F2A3CCQ38232199-F7ECB220-106F-4B26-8CB3-B0A87194FF95Q38398492-15C89D59-B242-4B2A-8A28-EB677FFEBA6AQ38686917-A79BA73B-0D49-4D2C-990E-E4326ACD29EFQ39279278-B1F82110-62AD-459D-B66F-F0DC2C8499BFQ40936660-810B7C5B-7E25-4EF0-8E96-0C999C193490Q41026343-DF19DBE0-54BA-44B1-9834-0570132B0C14Q41833657-C08C7D86-3C9B-4502-9C41-DA4D7A1B87BEQ42407674-021F6C1D-CA9F-402F-983A-06EE22654DA2
P2860
Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Activities of vancomycin-conta ...... er baumannii clinical strains.
@en
type
label
Activities of vancomycin-conta ...... er baumannii clinical strains.
@en
prefLabel
Activities of vancomycin-conta ...... er baumannii clinical strains.
@en
P2093
P2860
P356
P1476
Activities of vancomycin-conta ...... ter baumannii clinical strains
@en
P2093
Bethany M Townsend
Jessica A O'Hara
Lauretta A Ambe
Leila G Casella
Mark R Pelletier
Robert K Ernst
Robert M Q Shanks
P2860
P304
P356
10.1128/AAC.02501-12
P407
P50
P577
2013-02-19T00:00:00Z